129 related articles for article (PubMed ID: 23337597)
1. Polyoxometalate-biomolecule conjugates: a new approach to create hybrid drugs for cancer therapeutics.
Yang HK; Cheng YX; Su MM; Xiao Y; Hu MB; Wang W; Wang Q
Bioorg Med Chem Lett; 2013 Mar; 23(5):1462-6. PubMed ID: 23337597
[TBL] [Abstract][Full Text] [Related]
2. Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines.
Qamar S; Carrasquer CA; Cunningham SL; Cunningham AR
Anticancer Res; 2011 Oct; 31(10):3247-52. PubMed ID: 21965732
[TBL] [Abstract][Full Text] [Related]
3. Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cells.
Grau-Campistany A; Massaguer A; Carrion-Salip D; Barragán F; Artigas G; López-Senín P; Moreno V; Marchán V
Mol Pharm; 2013 May; 10(5):1964-76. PubMed ID: 23510087
[TBL] [Abstract][Full Text] [Related]
4. Discovery of polyoxometalate-based HDAC inhibitors with profound anticancer activity in vitro and in vivo.
Dong Z; Tan R; Cao J; Yang Y; Kong C; Du J; Zhu S; Zhang Y; Lu J; Huang B; Liu S
Eur J Med Chem; 2011 Jun; 46(6):2477-84. PubMed ID: 21481498
[TBL] [Abstract][Full Text] [Related]
5. A new Nb₂₈ cluster based on tungstophosphate, [{Nb₄O₆(OH)₄}{Nb₆P₂W₁₂O₆₁}₄]³⁶⁻.
Zhang D; Liang Z; Xie S; Ma P; Zhang C; Wang J; Niu J
Inorg Chem; 2014 Sep; 53(18):9917-22. PubMed ID: 25171493
[TBL] [Abstract][Full Text] [Related]
6. Polyoxometalate-Based Organic-Inorganic Hybrids as Antitumor Drugs.
Fu L; Gao H; Yan M; Li S; Li X; Dai Z; Liu S
Small; 2015 Jun; 11(24):2938-45. PubMed ID: 25721026
[TBL] [Abstract][Full Text] [Related]
7. Quercetin-POC conjugates: Differential stability and bioactivity profiles between breast cancer (MCF-7) and colorectal carcinoma (HCT116) cell lines.
Cho SY; Kim MK; Park KS; Choo H; Chong Y
Bioorg Med Chem; 2013 Apr; 21(7):1671-9. PubMed ID: 23434132
[TBL] [Abstract][Full Text] [Related]
8. Role of the alkali-metal cation size in the self-assembly of polyoxometalate-monolayer shells on gold nanoparticles.
Wang Y; Zeiri O; Sharet S; Weinstock IA
Inorg Chem; 2012 Jul; 51(14):7436-8. PubMed ID: 22515560
[TBL] [Abstract][Full Text] [Related]
9. Polyoxometalates as Potential Next-Generation Metallodrugs in the Combat Against Cancer.
Bijelic A; Aureliano M; Rompel A
Angew Chem Int Ed Engl; 2019 Mar; 58(10):2980-2999. PubMed ID: 29893459
[TBL] [Abstract][Full Text] [Related]
10. Folin-Ciocalteu Assay Inspired Polyoxometalate Nanoclusters as a Renal Clearable Agent for Non-Inflammatory Photothermal Cancer Therapy.
Zhou J; Zhao W; Miao Z; Wang J; Ma Y; Wu H; Sun T; Qian H; Zha Z
ACS Nano; 2020 Feb; 14(2):2126-2136. PubMed ID: 32027121
[TBL] [Abstract][Full Text] [Related]
11. Organometallic anticancer agents that interfere with cellular energy processes: a subtle approach to inducing cancer cell death.
Nazarov AA; Gardini D; Baquié M; Juillerat-Jeanneret L; Serkova TP; Shevtsova EP; Scopelliti R; Dyson PJ
Dalton Trans; 2013 Feb; 42(7):2347-50. PubMed ID: 23223548
[TBL] [Abstract][Full Text] [Related]
12. Cationic D4R zinc phosphate-anionic polyoxometalate hybrids: synthesis, spectra, structure and catalytic studies.
Kalita ACh; Roch-Marchal C; Murugavel R
Dalton Trans; 2013 Jul; 42(26):9755-63. PubMed ID: 23689293
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of conjugated Dawson-type polyoxometalate-porphyrin copolymers.
Azcarate I; Ahmed I; Farha R; Goldmann M; Wang X; Xu H; Hasenknopf B; Lacôte E; Ruhlmann L
Dalton Trans; 2013 Sep; 42(35):12688-98. PubMed ID: 23715240
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, cytotoxicity and antitumour mechanism investigations of polyoxometalate doped silica nanospheres on breast cancer MCF-7 cells.
Cao H; Li C; Qi W; Meng X; Tian R; Qi Y; Yang W; Li J
PLoS One; 2017; 12(7):e0181018. PubMed ID: 28704559
[TBL] [Abstract][Full Text] [Related]
15. Polyoxometalates as potent and selective inhibitors of alkaline phosphatases with profound anticancer and amoebicidal activities.
Raza R; Matin A; Sarwar S; Barsukova-Stuckart M; Ibrahim M; Kortz U; Iqbal J
Dalton Trans; 2012 Dec; 41(47):14329-36. PubMed ID: 23044850
[TBL] [Abstract][Full Text] [Related]
16. A Water-Soluble Antimony-Rich Polyoxometalate with Broad-Spectrum Antitumor Activities.
Xiao HP; Hao YS; Li XX; Xu P; Huang MD; Zheng ST
Angew Chem Int Ed Engl; 2022 Oct; 61(41):e202210019. PubMed ID: 35975881
[TBL] [Abstract][Full Text] [Related]
17. Designing, structural elucidation, comparison of DNA binding, cleavage, radical scavenging activity and anticancer activity of copper(I) complex with 5-dimethyl-2-phenyl-4-[(pyridin-2-ylmethylene)-amino]-1,2-dihydro-pyrazol-3-one Schiff base ligand.
Sathiyaraj S; Sampath K; Butcher RJ; Pallepogu R; Jayabalakrishnan C
Eur J Med Chem; 2013 Jun; 64():81-9. PubMed ID: 23644191
[TBL] [Abstract][Full Text] [Related]
18. New liposome-encapsulated-polyoxometalates: synthesis and antitumoral activity.
Wang X; Li F; Liu S; Pope MT
J Inorg Biochem; 2005 Feb; 99(2):452-7. PubMed ID: 15621277
[TBL] [Abstract][Full Text] [Related]
19. Facile assembly of hybrid materials containing polyoxometalate cluster anions and organic dye cations: crystal structures and initial spectral characterization.
Xie J; Abrahams BF; Wedd AG
Chem Commun (Camb); 2008 Feb; (5):576-8. PubMed ID: 18209794
[TBL] [Abstract][Full Text] [Related]
20. Growth factors and chemotherapeutic modulation of breast cancer cells.
Ciftci K; Su J; Trovitch PB
J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
